Reliq Health Technologies, Inc. Provides Update on Significant Expansion of Texas Medicaid Coverage, more than Doubling the E...
June 24 2021 - 3:01AM
Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or
WKN:A2AJTB) (“
Reliq” or the
“
Company”), a rapidly growing global telemedicine
company that develops innovative Virtual Care solutions for the
multi-billion dollar Healthcare market, today provided an update on
the recent expansion of Texas Medicaid’s Telemonitoring program,
which significantly increases the size of the eligible patient
population for Reliq’s services.
“Since its inception in 2014 to this point,
Texas Medicaid’s Telemonitoring (Remote Patient Monitoring) program
has only covered patients with two conditions - hypertension and
diabetes,” said Dr. Lisa Crossley, CEO of Reliq Health
Technologies. “With the recent passage of Bill HB-3740, effective
September 1, 2021 the Telemonitoring program in Texas is expanding
dramatically to include an additional nine eligible conditions:
pregnancy, heart disease, cancer, chronic obstructive pulmonary
disease, congestive heart failure, mental illness or serious
emotional disturbance, asthma, myocardial infarction and stroke,
more than doubling the size of the target patient population for
Reliq in this state. This significant change to the scope of Texas
Medicaid’s Telemonitoring program is consistent with the overall
trends in Medicare and Medicaid coverage for Remote Patient
Monitoring (RPM) and other virtual care services for patients with
chronic conditions. Since the federal Medicare program first
introduced its own billing code for RPM in 2018, the Centers for
Medicare and Medicaid Services have consistently expanded the
virtual care services covered and the total reimbursement amounts
every year. Using Reliq’s iUGO Care platform and its Remote Patient
Monitoring (RPM), Chronic Care Management (CCM), Behavioural Health
Integration (BHI), Collaborative Care Management (CoCM), Principal
Care Management (PCM) and Transitional Care Management (TCM)
modules, Reliq’s clients can currently leverage over 18 different
billing codes to provide high quality health care to their patients
remotely and generate new, high profit revenue streams for their
practices. The chronic condition management market is large and
rapidly growing, and Reliq’s industry-leading, powerful, flexible
iUGO Care platform is uniquely able to support healthcare providers
looking to offer new virtual care services to their patients.”
Reliq HealthReliq Health
Technologies is a rapidly growing global telemedicine company that
specializes in developing innovative Virtual Care solutions for the
multi-billion dollar Healthcare market. Reliq’s powerful iUGO Care
platform supports care coordination and community-based virtual
healthcare. iUGO Care allows complex patients to receive high
quality care at home, improving health outcomes, enhancing quality
of life for patients and families and reducing the cost of care
delivery. iUGO Care provides real-time access to remote patient
monitoring data, allowing for timely interventions by the care team
to prevent costly hospital readmissions and ER visits. Reliq Health
Technologies trades on the TSX Venture under the symbol RHT, on the
OTC as RQHTF and on the WKN as A2AJTB.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information please contact:
Company ContactInvestor Relations at
ir@reliqhealth.com
US Investor Relations ContactInvestor
RelationsLytham Partners, LLCBen ShamsianNew York |
Phoenix646-829-9701shamsian@lythampartners.com
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward
Looking Information
Certain statements in this press release
constitute forward-looking statements, within the meaning of
applicable securities laws. All statements that are not historical
facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives,
assumptions, expectations or beliefs of future performance, are
"forward-looking statements".
We caution you that such "forward-looking
statements" involve known and unknown risks and uncertainties that
could cause actual and future events to differ materially from
those anticipated in such statements.
Forward-looking statements include, but are not
limited to, statements with respect to commercial operations,
including technology development, anticipated revenues, projected
size of market, and other information that is based on forecasts of
future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the
"Company") does not intend and does not assume any
obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology
development and marketing activities, the Company's historical
experience with technology development, uninsured risks. Actual
results may differ materially from those expressed or implied by
such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
Reliq Health Technologies (TSXV:RHT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Reliq Health Technologies (TSXV:RHT)
Historical Stock Chart
From Sep 2023 to Sep 2024